Raymond James Issues Positive Forecast for Intuitive Surgical (NASDAQ:ISRG) Stock Price

Intuitive Surgical (NASDAQ:ISRG) had its price objective increased by equities researchers at Raymond James from $560.00 to $688.00 in a report issued on Friday,Benzinga reports. The brokerage presently has an “outperform” rating on the medical equipment provider’s stock. Raymond James’ price objective points to a potential upside of 17.31% from the stock’s previous close.

Other research analysts have also issued research reports about the stock. BTIG Research raised their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. Mizuho boosted their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research note on Friday, October 18th. Finally, Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $582.39.

Intuitive Surgical Stock Down 3.6 %

NASDAQ:ISRG traded down $22.17 during trading hours on Friday, reaching $586.49. 2,728,952 shares of the stock were exchanged, compared to its average volume of 1,885,801. Intuitive Surgical has a twelve month low of $364.17 and a twelve month high of $616.00. The business has a 50-day moving average of $546.03 and a two-hundred day moving average of $503.38. The company has a market capitalization of $208.90 billion, a price-to-earnings ratio of 94.49, a PEG ratio of 5.19 and a beta of 1.39.

Insider Activity

In related news, CFO Jamie Samath sold 270 shares of the stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. This represents a 2.99 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Robert Desantis sold 188 shares of the stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the completion of the sale, the executive vice president now owns 5,506 shares in the company, valued at $2,788,899.12. This represents a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 42,475 shares of company stock valued at $22,070,807 in the last ninety days. 0.90% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Intuitive Surgical

Several institutional investors and hedge funds have recently modified their holdings of the company. Berbice Capital Management LLC acquired a new stake in Intuitive Surgical during the 4th quarter worth approximately $26,000. Godsey & Gibb Inc. boosted its holdings in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical during the third quarter worth approximately $33,000. Decker Retirement Planning Inc. acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $36,000. Finally, Capital Performance Advisors LLP acquired a new position in shares of Intuitive Surgical in the 3rd quarter worth approximately $38,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.